Endometrial Cancer Treatment (Patient Version) – National Cancer Institute
Endometrial Cancer Treatment (PDQ®)–Health Professional Version
Endometrial Cancer Stage IIIC – Pubmed
Hemant Tongaonkar – Hinduja Hospital
Adjuvant therapy in stage III endometrial cancer confined to the pelvis.
Albeesh R, Turgeon GA, Alfieri J, Mansure JJ, Fu L, Arseneau J, Zeng X, Jardon K, Gilbert L, Souhami L. Gynecol Oncol. 2019 Jan;152(1):26-30. doi: 10.1016/j.ygyno.2018.11.002. Epub 2018 Nov 22.PMID: 30473258
Clinical Utility of Prospective Molecular Characterization in Advanced Endometrial Cancer.
Soumerai TE, Donoghue MTA, Bandlamudi C, Srinivasan P, Chang MT, Zamarin D, Cadoo KA, Grisham RN, O’Cearbhaill RE, Tew WP, Konner JA, Hensley ML, Makker V, Sabbatini P, Spriggs DR, Troso-Sandoval TA, Charen AS, Friedman C, Gorsky M, Schweber SJ, Middha S, Murali R, Chiang S, Park KJ, Soslow RA, Ladanyi M, Li BT, Mueller J, Weigelt B, Zehir A, Berger MF, Abu-Rustum NR, Aghajanian C, DeLair DF, Solit DB, Taylor BS, Hyman DM.
Clin Cancer Res. 2018 Dec 1;24(23):5939-5947. doi: 10.1158/1078-0432.CCR-18-0412. Epub 2018 Aug 1.PMID: 30068706 Free PMC Article
Prognostic Significance of Nodal Location and Ratio in Stage IIIC Endometrial Carcinoma Among a Multi-Institutional Academic Collaboration. Mayadev J, Elshaikh MA, Christie A, Nagel C, Kennedy V, Khan N, Lea J, Ghanem A, Miller D, Xie XJ, Folkert M, Albuquerque K. Am J Clin Oncol. 2018 Dec;41(12):1220-1224. doi: 10.1097/COC.0000000000000450.PMID: 29683799
Endometrial cancer.
Morice P, Leary A, Creutzberg C, Abu-Rustum N, Darai E. Lancet. 2016 Mar 12;387(10023):1094-1108. doi: 10.1016/S0140-6736(15)00130-0. Epub 2015 Sep 6. Review.
Patterns of FIRST recurrence of stage IIIC1 endometrial cancer with no PARAAORTIC nodal assessment. Aloisi A, Casanova JM, Tseng JH, Seader KA, Nguyen NT, Alektiar KM, Makker V, Chiang S, Soslow RA, Leitao MM Jr, Abu-Rustum NR. Gynecol Oncol. 2018 Dec;151(3):395-400. doi: 10.1016/j.ygyno.2018.09.021. Epub 2018 Oct 2.PMID: 30286945 Free PMC Article
Endometrial cancer state of the science meeting. Kitchener HC, Trimble EL; Endometrial Cancer Working Group of the Gynecologic Cancer Intergroup. Int J Gynecol Cancer. 2009 Jan;19(1):134-40. doi: 10.1111/IGC.0b013e3181995f90.PMID: 19258955
Epithelioid trophoblastic tumor of uterus presenting as an ovarian mass: a diagnostic and therapeutic dilemma. Shet T, Parage M, Maheshwari A, Nair R, Gupta S, Tongaonkar H, Chinoy R. Indian J Pathol Microbiol. 2008 Apr-Jun;51(2):242-4.PMID: 18603694 Free Article
Developing countries: an evolving opportunity for oncologic research. Badwe RA, D’cruz AK, Mistry RC, Tongaonkar HB, Shastri S, Thorat MA. World J Surg. 2006 Jul;30(7):1173-6. No abstract available.
Improving survival after endometrial cancer: the big picture
Janice S. Kwon J Gynecol Oncol. 2015 Jul; 26(3): 227–231. Published online 2015 Jul doi: 10.3802/jgo.2015.26.3.227PMCID: PMC4510340ArticlePubReaderPDF–855KCitation
Cancer prevention. Tongaonkar HB. Indian J Med Sci. 1998 Mar;52(3):108-13. Review. No abstract available. PMID: 9770873
Amita Maheshwari – Tata Memorial Hospital
Gynecological cancers: A summary of published Indian data.
Maheshwari A, Kumar N, Mahantshetty U. South Asian J Cancer. 2016 Jul-Sep;5(3):112-20. doi: 10.4103/2278-330X.187575. Review.PMID: 27606294 Free PMC Article
A proposal for updating the staging of endometrial cancer. Maheshwari A, Gupta S, Prat J. Int J Gynaecol Obstet. 2019 May;145(2):245-252. doi: 10.1002/ijgo.12789. Epub 2019 Mar 6.PMID: 30776091
Cytopathological features of scar endometriosis mimicking an adenocarcinoma: A diagnostic pitfall. Rekhi B, Sugoor P, Patil A, Shylasree TS, Kerkar R, Maheshwari A. J Cytol. 2013 Oct;30(4):280-3. doi: 10.4103/0970-9371.126672.PMID: 24648677 Free PMC Article
Changing Practice of Gynecologic Oncology based on Current Evidence. Tongaonkar HB. Med J Armed Forces India. 2004 Apr;60(2):102-6. doi: 10.1016/S0377-1237(04)80095-9. Epub 2011 Jul 21. No abstract available. PMID: 27407598 Free PMC Article
Clinical outcome of early-stage endometroid adenocarcinoma: a tertiary cancer center experience. Mahantshetty U, Aggarwal A, Ganesh B, Saoba S, Mulla S, Engineer R, Chopra S, Maheshwari A, Kerkar R, T S S, Ghosh J, Gupta S, Shrivasatava S. Int J Gynecol Cancer. 2013 Oct;23(8):1446-52. doi: 10.1097/IGC.0b013e3182a2ff46.PMID: 24257559
Sentinel lymph node mapping in endometrial cancer: a systematic review and meta-analysis. How JA, O’Farrell P, Amajoud Z, Lau S, Salvador S, How E, Gotlieb WH. Minerva Ginecol. 2018 Apr;70(2):194-214. doi: 10.23736/S0026-4784.17.04179-X. Epub 2017 Nov 28. Review.PMID: 29185673
Epithelioid trophoblastic tumor of uterus presenting as an ovarian mass: a diagnostic and therapeutic dilemma. Shet T, Parage M, Maheshwari A, Nair R, Gupta S, Tongaonkar H, Chinoy R. Indian J Pathol Microbiol. 2008 Apr-Jun;51(2):242-4.PMID: 18603694 Free Article
Adjuvant therapy for high-risk endometrial cancer: recent evidence and future directions. De Boer SM, Nout RA, Bosse T, Creutzberg CL. Expert Rev Anticancer Ther. 2019 Jan;19(1):51-60. doi: 10.1080/14737140.2019.1531708. Epub 2018 Oct 24. Review.PMID: 30295094
Does cytoreductive surgery followed by adjuvant chemo-radiotherapy decrease the risk of recurrence and death in stage III endometrial cancer? Verrengia A, Sigismondi C, Iannacone E, Bellia A, Busci L, Trezzi G, Malandrino C, Gianatti A, Frigerio L. Tumori. 2020 Feb 3:300891619900676. doi: 10.1177/0300891619900676. [Epub ahead of print]PMID: 32008470
Adjuvant External Radiation Impacts Outcome of Pelvis-limited Stage III Endometrial Carcinoma: A Multi-institutional Study. Albuquerque K, Folkert M, Mayadev J, Christie A, Liotta MR, Nagel C, Sevak P, Harkenrider MM, Lea JS, Hanna RK, Small WC Jr, Miller DS, Xie XJ, Potkul RK, Elshaikh MA. Am J Clin Oncol. 2018 Aug;41(8):792-796. doi: 10.1097/COC.0000000000000371.PMID: 28225446
Adjuvant chemotherapy for advanced endometrial cancer. Galaal K, Al Moundhri M, Bryant A, Lopes AD, Lawrie TA. Cochrane Database Syst Rev. 2014 May 15;(5):CD010681. doi: 10.1002/14651858.CD010681.pub2. Review.PMID: 24832785 Free PMC Article
Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial. de Boer SM, Powell ME, Mileshkin L, Katsaros D, Bessette P, Haie-Meder C, Ottevanger PB, Ledermann JA, Khaw P, Colombo A, Fyles A, Baron MH, Jürgenliemk-Schulz IM, Kitchener HC, Nijman HW, Wilson G, Brooks S, Carinelli S, Provencher D, Hanzen C, Lutgens LCHW, Smit VTHBM, Singh N, Do V, D’Amico R, Nout RA, Feeney A, Verhoeven-Adema KW, Putter H, Creutzberg CL; PORTEC study group.Lancet Oncol. 2018 Mar;19(3):295-309. doi: 10.1016/S1470-2045(18)30079-2. Epub 2018 Feb 12. Erratum in: Lancet Oncol. 2018 Apr;19(4):e184.
Management of Endometrial Cancer: A Review.
Suri V, Arora A. Rev Recent Clin Trials. 2015;10(4):309-16. Review.PMID: 26411949
Endometrial cancer: a review and current management strategies: part I. SGO Clinical Practice Endometrial Cancer Working Group, Burke WM, Orr J, Leitao M, Salom E, Gehrig P, Olawaiye AB, Bre
Endometrial cancer: a review and current management strategies: part II. SGO Clinical Practice Endometrial Cancer Working Group, Burke WM, Orr J, Leitao M, Salom E, Gehrig P, Olawaiye AB, Brewer M, Boruta D, Herzog TJ, Shahin FA; Society of Gynecologic Oncology Clinical Practice Committee. Gynecol Oncol. 2014 Aug;134(2):393-402. doi: 10.1016/j.ygyno.2014.06.003. Epub 2014 Jun 11. Review.PMID: 24929052